Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

784
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
784
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.3K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

602
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gaps in lipid screening and statin use among uninsured patients in a charitable community clinic.

American journal of preventive cardiology·2026
Same author

Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.

Journal of the American College of Cardiology·2026
Same author

Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.

Circulation·2026
Same author

Critical differences among stakeholders in definitions of success following inguinal hernia repair in older adults.

Surgery·2026
Same author

Advancing Women's Health Through Public Policy.

Circulation·2026
Same author

The Effect of an Exertion Protocol on Cognitive and Functional Performance in Adolescents After Concussion.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine·2026

Related Experiment Video

Updated: Apr 12, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K

Subclinical atherosclerosis and subsequent cognitive function.

Heidi C Rossetti1, Myron Weiner1, Linda S Hynan2

  • 1Department of Psychiatry, UT Southwestern Medical Center, USA.

Atherosclerosis
|May 11, 2015
PubMed
Summary
This summary is machine-generated.

Subclinical atherosclerosis showed minimal association with cognitive function in middle-aged adults. Measures like coronary artery calcium were weakly linked to cognitive scores, with no impact from ApoE4 status.

Keywords:
AtherosclerosisCognitionDallas heart studyMoCAMontreal Cognitive Assessment

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.5K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.8K

Related Experiment Videos

Last Updated: Apr 12, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.5K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.8K

Area of Science:

  • Cardiovascular Disease Pathogenesis
  • Neuroscience
  • Aging Research

Background:

  • Subclinical atherosclerosis, a precursor to overt cardiovascular disease, may impact cognitive function.
  • Understanding this relationship is crucial for identifying early risk factors for cognitive decline.

Purpose of the Study:

  • To investigate the association between subclinical atherosclerosis markers and cognitive function.
  • To explore potential moderating effects of age and ApoE4 status on this relationship.

Main Methods:

  • Utilized data from the Dallas Heart Study (DHS), including 1904 participants.
  • Assessed baseline subclinical atherosclerosis (coronary artery calcium, aortic plaque, aortic wall thickness) and follow-up cognitive function (Montreal Cognitive Assessment).

Main Results:

  • A trend of lower cognitive scores with increased atherosclerosis indicators was observed (p=.001).
  • Coronary artery calcium showed a weak correlation with cognitive scores (p=.047).
  • Abdominal aortic plaque and wall thickness had minimal association with cognitive function, and ApoE4 status did not influence the findings.

Conclusions:

  • Subclinical atherosclerosis demonstrated a minimal association with subsequent cognitive function in a diverse middle-aged population.
  • These findings suggest limited impact of common atherosclerosis measures on cognitive health in this demographic.